More reads
- Leading scientists, backed by NIH, call for a global moratorium on creating ‘CRISPR babies.’ (STAT)
- Hedge fund investing $100m in Harvard drug research. (Boston Globe)
- Amid the opioid crisis, a different drug comes roaring back. (Economist)
- Scholar Rock thinks Glaxo made a wise move to back Merck. (EP Vantage)
.png)
No hay comentarios:
Publicar un comentario